Judith Y. Altarejos

Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency

G. Yancopoulos, J. Gromada, M. Sleeman, 2023, Science Translational Medicine.